nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.181	0.197	CbGbCtD
Chlorzoxazone—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.155	0.168	CbGbCtD
Chlorzoxazone—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.133	0.145	CbGbCtD
Chlorzoxazone—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.103	0.112	CbGbCtD
Chlorzoxazone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0743	0.0809	CbGbCtD
Chlorzoxazone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0594	0.0647	CbGbCtD
Chlorzoxazone—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0503	0.0547	CbGbCtD
Chlorzoxazone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.039	0.0424	CbGbCtD
Chlorzoxazone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0362	0.0394	CbGbCtD
Chlorzoxazone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0291	0.0317	CbGbCtD
Chlorzoxazone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0166	0.0181	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0163	0.0178	CbGbCtD
Chlorzoxazone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0152	0.0166	CbGbCtD
Chlorzoxazone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0104	0.0113	CbGbCtD
Chlorzoxazone—Digestion impaired—Melphalan—peripheral nervous system neoplasm	0.00368	0.0452	CcSEcCtD
Chlorzoxazone—Lightheadedness—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.0274	CcSEcCtD
Chlorzoxazone—Lightheadedness—Tretinoin—peripheral nervous system neoplasm	0.00223	0.0274	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00181	0.0222	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00181	0.0222	CcSEcCtD
Chlorzoxazone—Lightheadedness—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.0208	CcSEcCtD
Chlorzoxazone—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00139	0.0171	CcSEcCtD
Chlorzoxazone—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00139	0.0171	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.0168	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.00117	0.0143	CcSEcCtD
Chlorzoxazone—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.013	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.00102	0.0125	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.0124	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.00101	0.0124	CcSEcCtD
Chlorzoxazone—Petechiae—Epirubicin—peripheral nervous system neoplasm	0.001	0.0123	CcSEcCtD
Chlorzoxazone—Angioedema—Topotecan—peripheral nervous system neoplasm	0.001	0.0123	CcSEcCtD
Chlorzoxazone—Malaise—Topotecan—peripheral nervous system neoplasm	0.000991	0.0122	CcSEcCtD
Chlorzoxazone—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.000983	0.0121	CcSEcCtD
Chlorzoxazone—Malaise—Tretinoin—peripheral nervous system neoplasm	0.000983	0.0121	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—peripheral nervous system neoplasm	0.00093	0.0114	CcSEcCtD
Chlorzoxazone—Discomfort—Topotecan—peripheral nervous system neoplasm	0.000924	0.0113	CcSEcCtD
Chlorzoxazone—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000917	0.0113	CcSEcCtD
Chlorzoxazone—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000917	0.0113	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000897	0.011	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00089	0.0109	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00089	0.0109	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000878	0.0108	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.000827	0.0101	CcSEcCtD
Chlorzoxazone—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000803	0.00986	CcSEcCtD
Chlorzoxazone—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000791	0.00971	CcSEcCtD
Chlorzoxazone—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000791	0.00971	CcSEcCtD
Chlorzoxazone—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000789	0.00969	CcSEcCtD
Chlorzoxazone—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000783	0.00961	CcSEcCtD
Chlorzoxazone—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000783	0.00961	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000774	0.0095	CcSEcCtD
Chlorzoxazone—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000773	0.00949	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000768	0.00943	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000768	0.00943	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000766	0.00941	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000758	0.00931	CcSEcCtD
Chlorzoxazone—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000749	0.0092	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.000748	0.00918	CcSEcCtD
Chlorzoxazone—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.00915	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000739	0.00907	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000733	0.009	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000733	0.009	CcSEcCtD
Chlorzoxazone—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000695	0.00853	CcSEcCtD
Chlorzoxazone—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.00849	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000674	0.00828	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000653	0.00802	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00065	0.00798	CcSEcCtD
Chlorzoxazone—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000635	0.00779	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.0006	0.00737	CcSEcCtD
Chlorzoxazone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.00736	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000599	0.00736	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000598	0.00734	CcSEcCtD
Chlorzoxazone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000593	0.00729	CcSEcCtD
Chlorzoxazone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000593	0.00728	CcSEcCtD
Chlorzoxazone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000592	0.00727	CcSEcCtD
Chlorzoxazone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000588	0.00722	CcSEcCtD
Chlorzoxazone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000588	0.00722	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.00715	CcSEcCtD
Chlorzoxazone—Malaise—Etoposide—peripheral nervous system neoplasm	0.000581	0.00714	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000574	0.00705	CcSEcCtD
Chlorzoxazone—Rash—Topotecan—peripheral nervous system neoplasm	0.000565	0.00694	CcSEcCtD
Chlorzoxazone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000565	0.00694	CcSEcCtD
Chlorzoxazone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000561	0.00689	CcSEcCtD
Chlorzoxazone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000561	0.00689	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000561	0.00689	CcSEcCtD
Chlorzoxazone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00056	0.00688	CcSEcCtD
Chlorzoxazone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00056	0.00688	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.00682	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.00682	CcSEcCtD
Chlorzoxazone—Rash—Melphalan—peripheral nervous system neoplasm	0.000554	0.0068	CcSEcCtD
Chlorzoxazone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000553	0.00679	CcSEcCtD
Chlorzoxazone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000542	0.00666	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000526	0.00646	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000496	0.00609	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000473	0.00581	CcSEcCtD
Chlorzoxazone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000468	0.00574	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000463	0.00568	CcSEcCtD
Chlorzoxazone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000458	0.00563	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000454	0.00558	CcSEcCtD
Chlorzoxazone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00547	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000434	0.00532	CcSEcCtD
Chlorzoxazone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00043	0.00527	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.00525	CcSEcCtD
Chlorzoxazone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00522	CcSEcCtD
Chlorzoxazone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00521	CcSEcCtD
Chlorzoxazone—Rash—Vincristine—peripheral nervous system neoplasm	0.00041	0.00503	CcSEcCtD
Chlorzoxazone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000409	0.00502	CcSEcCtD
Chlorzoxazone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00445	CcSEcCtD
Chlorzoxazone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00444	CcSEcCtD
Chlorzoxazone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000348	0.00427	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000335	0.00412	CcSEcCtD
Chlorzoxazone—Rash—Etoposide—peripheral nervous system neoplasm	0.000332	0.00407	CcSEcCtD
Chlorzoxazone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000331	0.00407	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000326	0.004	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00381	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00373	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.0037	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000295	0.00362	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.00345	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.00335	CcSEcCtD
Chlorzoxazone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00322	CcSEcCtD
Chlorzoxazone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00319	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000255	0.00313	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00298	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00298	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00295	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.00289	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00276	CcSEcCtD
Chlorzoxazone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00239	CcSEcCtD
Chlorzoxazone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00228	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00228	CcSEcCtD
Chlorzoxazone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00222	CcSEcCtD
Chlorzoxazone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00211	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00211	CcSEcCtD
